Table 5 Annual number of HPV 6/11/16/18 events prevented by quadrivalent HPV vaccination of 12 to 17 year old girls in Germany and screening, compared with screening alone
| Â | Annual number of disease events prevented | ||||
|---|---|---|---|---|---|
Time since start of vaccination programme (years) | |||||
| Â | 5 | 15 | 25 | 50 | 100 |
Cervical cancer | 5 | 298 | 953 | 2,474 | 2,955 |
Cervical cancer deaths | 0 | 21 | 135 | 559 | 720 |
CIN 2/3 | 1,711 | 9,288 | 12,694 | 14,899 | 15,429 |
CIN 1 | 899 | 3,552 | 4,366 | 4,751 | 4,829 |
Genital warts | |||||
  female | 16,350 | 30,780 | 33,001 | 35,075 | 36,049 |
  male | 13,874 | 26,999 | 27,172 | 25,948 | 25,691 |
  Total | 30,225 | 57,779 | 60,173 | 61,023 | 61,740 |
HPV 16/18 events | 2,322 | 12,134 | 16,876 | 20,906 | 21,966 |
HPV 6/11 events | 30,518 | 58,783 | 61,309 | 62,241 | 62,987 |